4//SEC Filing
Winton Matthew 4
Accession 0000950170-25-090868
CIK 0001693011other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:05 PM ET
Size
5.0 KB
Accession
0000950170-25-090868
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2025-06-25$0.74/sh+14,355$10,623→ 21,743 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2025 through June 25, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on April 1, 2025, the first trading day of the purchase period.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001971400
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:05 PM ET
- Size
- 5.0 KB